zPREDICTA is developing an in vitro human airway model to screen new and repurposed agents against SARS-CoV-2. Our reconstructed lung (r-Lung-SARS-CoV-2) platform is designed to assist pharmaceutical, biotech, and academic researchers in identifying antivirals for COVID-19.

zPREDICTA

San Jose

zPREDICTA startup from San Jose, United States is ranked 1419 out of 2449 worldwide and 515 from the 748 startups in United States. See more information and additional rankings on the StartupBlink Global Ecosystem Map